S100A12 levels in synovial fluid may reflect clinical severity in patients with primary knee osteoarthritis

References

• Altman R, Asch E, Bloch D, et al. (1986). Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29:1039–49
   PubMed Web of Science ®Google Scholar
• Baillet A, Trocmé C, Berthier S, et al. (2010). Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases. Rheumatology (Oxford) 49:671–82
   PubMed Web of Science ®Google Scholar
• Bellamy N, Buchanan WW, Goldsmith CH, et al. (1988). Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–40
   PubMed Web of Science ®Google Scholar
• Chayanupatkul M, Honsawek S. (2010). Soluble receptor for advanced glycation end products (sRAGE) in plasma and synovial fluid is inversely associated with disease severity of knee osteoarthritis. Clin Biochem 43:1133–7
   PubMed Web of Science ®Google Scholar
• Donato R. (2001). S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33:637–68
   PubMed Web of Science ®Google Scholar
• Felson DT, Zhang Y, Hannan MT, et al. (1995). The incidence and natural history of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum 38:1500–5
   PubMed Web of Science ®Google Scholar
• Foell D, Kane D, Bresnihan B, et al. (2003). Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology (Oxford) 42:1383–9
   PubMed Web of Science ®Google Scholar
• Gerss J, Roth J, Holzinger D, et al. (2012). Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study. Ann Rheum Dis 71:1991–7
   PubMed Web of Science ®Google Scholar
• Han EC, Cho SB, Ahn KJ, et al. (2011). Expression of pro-inflammatory protein S100A12 (EN-RAGE) in Behçet’s disease and its association with disease activity: a pilot study. Ann Dermatol 23:313–20
   PubMed Web of Science ®Google Scholar
• Henrotin Y. (2012). Osteoarthritis year 2011 in review: biochemical markers of osteoarthritis: an overview of research and initiatives. Osteoarthritis Cart 20:215–17
   PubMed Web of Science ®Google Scholar
• Kellgren JH, Lawrence JS. (1957). Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494–502
   PubMed Web of Science ®Google Scholar
• Kosaki A, Hasegawa T, Kimura T, et al. (2004). Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetes. J Clin Endocrinol Metab 89:5423–8
   PubMed Web of Science ®Google Scholar
• Li ZC, Cheng GQ, Hu KZ, et al. (2011). Correlation of synovial fluid HMGB-1 levels with radiographic severity of knee osteoarthritis. Clin Invest Med 34:E298--303
   Google Scholar
• Loeser RF, Goldring SR, Scanzello CR, Goldring MB. (2012). Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum 64:1697–707
   PubMed Web of Science ®Google Scholar
• Meijer B, Gearry RB, Day AS. (2012). The role of S100A12 as a systemic marker of inflammation. Int J Inflam 2012:1--6, Article ID 907078
   Google Scholar
• Myles A, Viswanath V, Singh YP, Aggarwal A. (2011). Soluble receptor for advanced glycation endproducts is decreased in patients with juvenile idiopathic arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels. J Rheumatol 38:1994–9
   PubMed Web of Science ®Google Scholar
• Nakashima M, Sakai T, Hiraiwa H, et al. (2012). Role of S100A12 in the pathogenesis of osteoarthritis. Biochem Biophys Res Commun 422:508–14
   Google Scholar
• Perera C, McNeil HP, Geczy CL. (2010). S100 Calgranulins in inflammatory arthritis. Immunol Cell Biol 88:41–9
   PubMed Web of Science ®Google Scholar
• Pullerits R, Bokarewa M, Dahlberg L, Tarkowski A. (2005). Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis Res Ther 7:R817–24
   PubMed Web of Science ®Google Scholar
• Rousseau JCh, Garnero P. (2012). Biological markers in osteoarthritis. Bone 51:265–77
   PubMed Web of Science ®Google Scholar
• Stürmer T, Brenner H, Koenig W, Günther KP. (2004). Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein. Ann Rheum Dis 63:200–5
   PubMed Web of Science ®Google Scholar
• Xu L, Zhu GB, Wang L, et al. (2012). Synovial fluid omentin-1 levels are inversely correlated with radiographic severity of knee osteoarthritis. J Investig Med 60:583–6
   PubMed Web of Science ®Google Scholar